The focus of this topic is the integration and synergy of knowledge from engineering and medical / clinical research to develop medical devices, systems and software for the prevention and (early) diagnosis of diseases for better therapy stratification. We interpret “medical engineering for health” as being the application of knowledge from the areas of engineering sciences, molecular basic research and bioinformatics in the field of medicine. Consequently, knowledge from these areas is combined with medical expertise aiming at better diagnostics, therapy and therapeutic management of patients. This is comprising research and development of new diagnostic methods, medical devices, systems, algorithms and software, prostheses and implants for recognition, prevention, monitoring, treatment or relief of diseases, injury and disabilities.
Medical Technology for Health (MTH)
HEiKA-Projects of this research bridge
- Prof. Dr. Gergana Dobreva / Prof. Dr. Ute Schepers3D bioprinting of heart tissue for transplantation - Effects of materials and endothelial factors on stem cell maturation to functional myocardial tissue
- Prof. (apl.) Dr. Dr. Christian Freudlsperger / Prof. Dr. Werner NahmA radiation free, deep learning based classification of craniofacial deformities on surface scans. Paving the methodical way towards a patient’s digital twin.
- Prof. Dr. med. Marc Fatar / PD Dr. rer. nat. Nicole RuiterMagnetic resonance-guided opening of the blood-brain barrier using focused ultrasound for cell-mediated therapies of brain diseases
- Prof. Dr. Dr. Jürgen Debus / Prof. Dr. Ivan Peric
- Prof. Dr. Markus Schwarz / Prof. Dr. Andreas Guber3D gedruckte Nano-Zellgerüstträger für die in situ Knorpelregeneration zur Behandlung von Gelenkknorpelschäden. Untersuchungen zum Zellrecruitment in einem Bioreaktor.
- Prof. Dr. med. Matthias Friedrich / Prof. Dr. rer. nat. Olaf DösselImproved Phenotyping of Cardiomypathy Patients by Means of Imaging-Driven Computational Modeling of Cardiac Biomechanics
- PD Dr. med. Philipp Erben / Prof. Dr. Andreas GuberInvasions- und Genexpressionsanalysen im Urothelkarzinom der Harnblase: Entwicklung eines mikrofluidischen in vitro Lymphgefäßmodells